glp-1 agonists addiction Weight Loss Drugs May Also Curb Substance Use Disorders GLP-1 Analogues in the Neurobiology
Description
The Phase III trial of this pipeline drug for treating type 2 diabetes mellitus, non-alcoholic fatty liver disease, and obesity started on August 28, 2023
Few categories in modern medicine have captured the imagination of patients, physicians, and investors as quickly as GLP-1 receptor agonists (GLP-1s)
Green tea, gymnema, turmeric, and B vitamins provide antioxidant and metabolic support
PHILADELPHIA While celebrities and diabetes patients alike have heralded the swift success of Ozempic and similar drugs, more than 900 complaints...
Researchers conducted a prospective single-center cohort study of adults with a BMI of 27 kg/m2 or higher using liraglutide (Victoza/Saxenda, Novo Nordisk) or semaglutide (Ozempic/Wegovy, Novo Nordisk)
Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof
